News

Sickle cell trait (SCT), long believed to be a benign carrier condition, is now being recognized for its association with various health complications. Despite its…

The reni-cel experimental gene therapy for severe sickle cell disease continues to show promising results. Now tested in a full cohort of 40 patients, some with…

Young adults with complex chronic childhood-onset conditions such as sickle cell disease and cystic fibrosis experience…

Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide…

A new, fast and easy test could revolutionize blood transfusions-giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after…

Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends.It was a contrast to how Cole, 18,…

In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-…

Living with sickle cell disease requires more of a patient than just managing symptoms. One major necessity is the ability to effectively communicate one’s needs.…

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms…

The global sickle cell disease treatment market size was estimated at USD 2,758.5 million in 2023 and is projected to reach USD 7,422.4 million by 2030, growing at…